Jacobs Levy Equity Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,826
Closed -$272K 1055
2023
Q3
$272K Sell
16,826
-111,125
-87% -$1.97M ﹤0.01% 887
2023
Q2
$2.44M Sell
127,951
-86,966
-40% -$1.55M 0.01% 536
2023
Q1
$3.13M Buy
+214,917
New +$3.85M 0.02% 484
2021
Q1
Sell
-43,060
Closed -$1.17M 1094
2020
Q4
$1.17M Sell
43,060
-169,365
-80% -$4.36M 0.01% 683
2020
Q3
$5.33M Sell
212,425
-401,955
-65% -$5.86M 0.06% 330
2020
Q2
$4.68M Sell
614,380
-181,170
-23% -$1.33M 0.05% 352
2020
Q1
$7.28M Buy
795,550
+238,003
+43% +$1.44M 0.09% 232
2019
Q4
$2.88M Sell
557,547
-173,312
-24% -$1.11M 0.03% 480
2019
Q3
$4.25M Buy
+730,859
New +$3.28M 0.05% 364
2017
Q4
Sell
-19,917
Closed -$582K 1041
2017
Q3
$582K Sell
19,917
-95,703
-83% -$2.83M 0.01% 682
2017
Q2
$3.72M Sell
115,620
-5,690
-5% -$187K 0.08% 289
2017
Q1
$4.2M Hold
121,310
0.08% 286
2016
Q4
$4.28M Hold
121,310
0.08% 275
2016
Q3
$4.21M Buy
121,310
+8,340
+7% +$292K 0.08% 291
2016
Q2
$4.22M Hold
112,970
0.09% 271
2016
Q1
$4.57M Buy
112,970
+71,590
+173% +$2.67M 0.1% 240
2015
Q4
$1.49M Buy
+41,380
New +$1.5M 0.03% 392

Other funds holding ACH

Jacobs Levy Equity Management's ACH Position: Q4 2023 in Review

Jacobs Levy Equity Management sold out of Accendra Health (ACH) in Q4 2023, closing a stake of 16,826 shares — an estimated $272K sold.

Jacobs Levy Equity Management first reported a position in ACH in Q4 2015 and held it in 17 quarters. The position peaked at $7.28M in Q1 2020. 227 funds tracked by Wall St. Rank hold ACH as of Q4 2023.

  • Jacobs Levy Equity Management reported no remaining Accendra Health position as of Q4 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 16,826 Accendra Health shares in Q4 2023, an estimated $272K.
  • Jacobs Levy Equity Management first reported a position in Accendra Health in Q4 2015 and held it in 17 quarters.
  • Jacobs Levy Equity Management's Accendra Health position peaked at $7.28M in Q1 2020.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q4 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.